These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 23645748

  • 1. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP, Sheets TP, Johnston DS.
    Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
    [Abstract] [Full Text] [Related]

  • 2. Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers.
    Vogl TJ, Zangos S, Scholtz JE, Schmitt F, Paetzold S, Trojan J, Orsi F, Lotz G, Ferrucci P.
    Rofo; 2014 Oct; 186(10):937-44. PubMed ID: 24729409
    [Abstract] [Full Text] [Related]

  • 3. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.
    Deneve JL, Choi J, Gonzalez RJ, Conley AP, Stewart S, Han D, Werner P, Chaudhry TA, Zager JS.
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1480-7. PubMed ID: 22699779
    [Abstract] [Full Text] [Related]

  • 4. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
    Dewald CLA, Becker LS, Maschke SK, Meine TC, Alten TA, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Hinrichs JB.
    Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
    [Abstract] [Full Text] [Related]

  • 6. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
    Artzner C, Mossakowski O, Hefferman G, Grosse U, Hoffmann R, Forschner A, Eigentler T, Syha R, Grözinger G.
    Cancer Imaging; 2019 May 30; 19(1):31. PubMed ID: 31146793
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
    Rothbarth J, Koevoets C, Tollenaar RA, Tilby MJ, van de Velde CJ, Mulder GJ, Kuppen PJ.
    Biochem Pharmacol; 2004 May 01; 67(9):1771-8. PubMed ID: 15081876
    [Abstract] [Full Text] [Related]

  • 8. Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review.
    Vogel A, Gupta S, Zeile M, von Haken R, Brüning R, Lotz G, Vahrmeijer A, Vogl T, Wacker F.
    Adv Ther; 2017 Jan 01; 33(12):2122-2138. PubMed ID: 27798773
    [Abstract] [Full Text] [Related]

  • 9. Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter.
    Dewald CLA, Meine TC, Winther HMB, Kloeckner R, Maschke SK, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Renne J, Hinrichs JB.
    Cardiovasc Intervent Radiol; 2019 Oct 01; 42(10):1441-1448. PubMed ID: 31089781
    [Abstract] [Full Text] [Related]

  • 10. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
    Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Sep 01; 56(3):279-85. PubMed ID: 15875187
    [Abstract] [Full Text] [Related]

  • 11. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
    Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F.
    Cardiovasc Intervent Radiol; 2022 Feb 01; 45(2):218-222. PubMed ID: 34716470
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors.
    Kirstein MM, Marquardt S, Jedicke N, Marhenke S, Koppert W, Manns MP, Wacker F, Vogel A.
    J Cancer Res Clin Oncol; 2017 Oct 01; 143(10):2113-2121. PubMed ID: 28634727
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.
    Chang YF, Li LL, Wu CW, Liu TY, Lui WY, P'eng FK, Chi CW.
    Cancer; 1996 Jan 01; 77(1):14-8. PubMed ID: 8630921
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro.
    Miklášová N, Fischer-Fodor E, Lönnecke P, Tomuleasa CI, Virag P, Schrepler MP, Mikláš R, Dumitrescu LS, Hey-Hawkins E.
    Eur J Med Chem; 2012 Mar 01; 49():41-7. PubMed ID: 22305340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemosaturation of the Liver - an Update.
    Ebel S, Struck MF, van Boemmel F, Beeskow AB, Gößmann H, Denecke T.
    Rofo; 2023 Jan 01; 195(1):30-37. PubMed ID: 35977553
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.
    Vogel A, Ochsenreither S, Zager JS, Wacker F, Saborowski A.
    Cancer Treat Rev; 2023 Feb 01; 113():102501. PubMed ID: 36587472
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.